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Systematic Review
The Natural History of Degenerative
Cervical Myelopathy and the Rate of
Hospitalization Following Spinal Cord
Injury: An Updated Systematic Review
Lindsay A. Tetreault, PhD1,2, Spyridon Karadimas, MD1,
Jefferson R. Wilson, MD, PhD3, Paul M. Arnold, MD4,5, Shekar Kurpad, MD, PhD6,
Joseph R. Dettori, PhD, MPH7, and Michael G. Fehlings, MD, PhD, FRCSC, FACS1,3
Abstract
Study Method: Systematic review (update).
Objective: Degenerative cervical myelopathy (DCM) is a degenerative spine disease and the most common cause of spinal cord
dysfunction in adults worldwide. The objective of this study is to determine the natural history of DCM by updating the systematic
review by Karadimas et al. The specific aims of this review were (1) to describe the natural history of DCM and (2) to determine
potential risk factors of disease progression.
Method: An updated search based on a previous protocol was conducted in PubMed and the Cochrane Collaboration library for
studies published between November 2012 and February 15, 2015.
Results: The updated search yielded 3 additional citations that met inclusion criteria and reported the incidence of spinal
cord injury and severe disability in patients with DCM. Based on 2 retrospective cohort studies, the incidence rate of
hospitalization for spinal cord injury is 13.9 per 1000 person-years in patients with cervical spondylotic myelopathy and
4.8 per 1000 person-years in patients with myelopathy secondary to ossification of the posterior longitudinal ligament
(OPLL). In a third small prospective study, the risk of being wheelchair bound or bedridden was 66.7% in DCM patients
with OPLL.
Conclusion: The overall level of evidence for these estimated rates of hospitalization following spinal cord injury was rated as low.
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Introduction
Degenerative cervical myelopathy (DCM) is a degenerative
spine disease and the most common cause of spinal cord dys-
function in adults worldwide.1 The term DCM encompasses
cord compression secondary to osteoarthritic changes to the
spine, disc degeneration, ligamentous aberrations, and progres-
sive kyphosis. Patients with DCM may present with a wide
range of neurological signs and symptoms, including pain,
lower limb spasticity, decreased hand dexterity, hyperreflexia,
and sphincter disturbance.
The pattern of progression in DCM is not well defined.
Early reports of the natural history suggest that DCM is a
relatively benign disorder and that patients are more likely to
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remain stable over time than to deteriorate.2 In the most recent
systematic review of the literature, there was moderate evi-
dence that 20% to 62% of patients with symptomatic myelo-
pathy will decline by at least 1 point on the Japanese
Orthopaedic Association scale if not managed surgically.3 The
objective of this study was to update the systematic review by
Karadimas et al3 that investigated (1) the natural history of
DCM and (2) the potential risk factors of disease progression.
Materials and Methods
Electronic Literature Search
An updated search based on a previous protocol4 was conducted in
PubMed and the Cochrane Collaboration library for studies pub-
lished between November 2012 and February 15, 2015. Inclusion
and exclusion criteria for the search were previously published, as
well as methods for data abstraction, data analysis, evaluation of
study quality, and assessment of the overall strength of evidence.
Results
Study Selection
The updated electronic search yielded 122 new citations (Fig-
ure 1). An additional 40 citations were identified through
directed manual search. One hundred and fifty-seven studies
were excluded following title and abstract review, and 5 studies
were further investigated. Following full text review, a single
study was excluded because all patients underwent surgery for
DCM, and another for including nonmyelopathic patients
with ossification of the posterior longitudinal ligament (OPLL;
Table 1).5 Three other studies presented new information relevant
to key question 1 and reported the incidence of spinal cord injury
and severe disability in patients with DCM.6-8
Two retrospective cohort studies used the National Health
Insurance Research Database, which contains records for 23
million administered insurants in Taiwan (approximately 99%
of the entire population).7,8 The first study included 14140
patients hospitalized for cervical spondylotic myelopathy
(CSM) with at least 1 year of follow-up (Table 2).8 The second
study consisted of 5604 patients with myelopathy secondary to
OPLL and at least 3 years of follow-up.7 A third prospective
Figure 1. Results of updated and originally published literature searches. KQ ¼ key question.
Table 1. Excluded Studies and Reasons for Exclusion.
Author (Year) Reasons for Exclusion
Kalb et al (2011) Surgery study
Matsunaga (2008) Wrong population: Asymptomatic OPLL
Abbreviation: OPLL, ossification of the posterior longitudinal ligament.
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cohort study reported outcomes on 450 patients with myelo-
pathy secondary to OPLL; however, only 36 were managed
conservatively after refusing surgical treatment.
Hospitalization for Spinal Cord Injury
Based on 2 retrospective cohort studies, the incidence rate
of hospitalization for spinal cord injury was 13.9 per 1000
person-years (95% confidence interval [CI] ¼ 11.6-16.6) in
patients diagnosed with CSM8 and 4.8 per 1000 person-
years (95% CI ¼ 2.3-10.1) in patients with myelopathy
secondary to OPLL7 (Table 3). The rate of hospitalization
for spinal cord injury in patients with DCM from OPLL was
significantly higher than the rate observed in a healthy pop-
ulation (0.18 per 1000 person-years; hazard ratio ¼ 32.2;
95% CI ¼ 10.4-99.0; P < .001).7 These studies both had
moderately low risk of bias (Table 4).
Disability
One large retrospective study evaluated the incidence of severe
neurological deficits from spinal cord injury in patients with
CSM, including paraplegia, tetraplegia, and incontinence; the
reported rate was 3.4 per 1000 person-years.7 A second small
prospective study reported that the risk of being wheelchair
bound or bedridden was 66.7% (24/36) in patients with DCM
Table 3. Incidence Rate or Risk of Spinal Cord Injury and Disability in Patients Not Treated Surgically.
Outcome Study Risk of Bias Diagnosis N Person-Years or Number of Persons Incidence Rate or Riska (95% CI)
SCIb Wu (2013) Moderately low CSM 122 8776.7 13.9 (11.6-16.6)
Wu (2012) Moderately low OPLLc 7 1455.2 4.8 (2.3-10.1)
Disabilityd Wu (2012)7 Moderately low OPLLc 5 1463.6 3.4 (1.5-8.0)
Matsunaga (2004)6 Moderately high OPLLc 24 36 66.7%
Abbreviations: CI, confidence interval; SCI, spinal cord injury; CSM, cervical spondylotic myelopathy; OPLL, ossification of the posterior longitudinal ligament;
DCM, degenerative cervical myelopathy.
aRate is per 1000 person-years; risk ¼ percentage.
bDefined as hospitalizations for SCI.
cDCM secondary to OPLL
dWu (2012) defined disability as severe neurological deficits caused by SCI such as paraplegia, tetraplegia, and incontinence; Matsunaga (2004) defined disability as
becoming wheelchair bound or bedridden.
Table 4. Class of Evidence for Prognostic Studies.
Methodological Principle
Wu
(2013)8
Wu
(2012)7
Matsunaga
(2004)6
Study design
Prospective cohort study P
Retrospective cohort study P P
Case-control study
Case series
Patients at similar point in the course of
their disease or treatment
P P
Patients followed long enough for
outcome to occur
P P P
Complete follow-up of 80% P P
Controlling for extraneous prognostic
factorsa
P P
aAuthors must summarize baseline characteristics, and control for those that
differ between treatment groups.
Table 2. Characteristics of New Studies Addressing the Natural History of DCM.
Author (Year)/Study
Design Patient Characteristics
Mean Follow-up;
% Follow-up Inclusion Criteria
Wu et al (2013)8/
Retrospective cohort
N ¼ 14140; mean
age ¼ NR; % male NR
1 year; % NR Subjects hospitalized and discharged with the
diagnostic ICD-9 code for CSM (721.1)
(National Health Research Institute of Taiwan)
Wu et al (2012)7/
Retrospective cohort
N ¼ 5604; mean age ¼
60.35+ 14 years; 70% male
3 years; % NR Subjects hospitalized within the study period with
a first time discharge summary containing the
diagnostic ICD-9 code for OPLL (723.7x)
(National Health Research Institute of Taiwan)
Patients hospitalized for OPLL who have not received
spinal intervention within the previous 6 months
(National Health Research Institute of Taiwan)
Matsunaga et al (2004)6/
Prospective cohort
N¼ 36a; mean age¼ 61.8 years;
59% male
17.6 years (range ¼
10-30 years); % NR
Patients with DCM from OPLL
Abbreviations: DCM, degenerative cervical myelopathy; ICD-9, International Classification of Diseases, Ninth Edition; CSM, cervical spondylotic myelopathy; NR,
not reported; OPLL, ossification of the posterior longitudinal ligament.
aN ¼ 450 in study; 36 patients were treated conservatively for myelopathy symptoms.
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Table 5. Evidence Summary.
Strength of
Evidence Conclusions/Comments Baselinea
Upgrade
(Levels)b
Downgrade
(Levels)c
What is the natural history of CSM?
Neurological outcome
 JOA change
compared with
baseline
Moderate  Although mean scores tend to remain constant, there is
moderate evidence (2 small prospective9,10 and 4 small
retrospective10–13 observational studies) that 20% to
62% of patients will deteriorate (at least 1 point on the
JOA) 3-6 years after initial assessment. Proportions vary
based on definition of deterioration.
High Risk of bias (1)
 Nurick Grade
change compared
with baseline
Very Low  There is very low evidence from one small retrospective
observational study (N ¼ 76)14 that a majority of DCM
patients will not experience a change on the Nurick over
time with nonoperative treatment. Sixty-seven percent
of patients were stable, 20% improved, and 13%
deteriorated after 8 years.
Low Inconsistent (1)
 Spinal cord injury Low  There is low-level evidence that the rate of
hospitalization for spinal cord injury is 13.9 per 1000
person-years in patients with CSM.8 The rate is 4.8 per
1000 person-years in patients with DCM from OPLL and
0.18 per 1000 person-years in a healthy population (HR
¼ 32.2; 95% CI ¼ 10.4-99.0).7
Low
 Disability Low  There is low-level evidence that the rate of severe
disability is 3.4 per 1000 person-years in patients with
DCM secondary to OPLL.7
Low
 Conversion to
surgery
Very Low  There is very low evidence (2 small prospective10,15,16
and 4 small retrospective observational studies)11,17–19
that the proportion of patients undergoing surgery
following worsening of symptoms increases over time.
The proportion of patients converting to surgery ranges
from 4% to 40% over 3 to 7 years, respectively.
Low Imprecise (1)
Functional outcome
 Activities of daily
living
Moderate  There is moderate evidence (2 small prospective studies,
N¼ 3120 and N¼ 3321) that patients with DCM worsen
in performing activities of daily living (ADL) with
nonoperative treatment. One study reported 6%, 21%,
28%, and 56% worsening of ADL from baseline values at
1-, 2-, 3-, and 10-years follow-up, respectively.
High Risk of bias (1)
 Timed 10-meter
walk
Very Low  There is very low evidence (one small prospective study,
N ¼ 3321) that there is no significant difference in
10-meter walking test times between baseline and 1-, 2-,
3-, and 10-years following conservative treatment.
High Risk of bias (1);
Imprecise (1);
Inconsistent (1)
 Overall functional
status
Very Low  There is very low evidence (one small prospective
observational study, N¼ 3120) that the overall functional
status improves over time in patients treated
conservatively for DCM.
Low Inconsistent (1)
Are there risk factors that affect the progression of DCM?
Neurological outcome
Demographic characteristics
 Age Very Low  There is very low evidence to support the association
between age at diagnosis and neurological deterioration
based on the JOA. One prospective study reported no
association using multivariate analysis;13 one prospective
study reported that older age (mean 58 years) before
treatment was a positive predictor for neurological
improvement (P < .05);9 and one retrospective study
reported that younger age (<52 years) was a positive
predictor for neurological improvement using
univariate analysis.17
Low Inconsistent (1);
Imprecise (1)
(continued)
Tetreault et al 31S
Table 5. (continued)
Strength of
Evidence Conclusions/Comments Baselinea
Upgrade
(Levels)b
Downgrade
(Levels)c
 Sex Very Low  There is very low evidence to support the association
between sex and neurological progression of myelopathy
on the JOA. One prospective study reported no
association using multivariate analysis10 and one
retrospective study indicated that female sex was
associated with a progressively worse neurological
condition (P < .05).20
Low Inconsistent (1);
Risk of bias (1)
 Height Very Low  There is very low evidence (one prospective study) that
lower body height (mean 170 cm) is a positive predictor
of JOA improvement (P < .05).9
High Imprecise (1);
Inconsistent (1)
Radiographic characteristics
 Circumferential
spinal cord
compression
Low  There is low evidence (one prospective study using
multivariate analysis) that circumferential spinal cord
compression (compared with only partial cord
compression) is associated with neurological
deterioration (JOA) (adjusted OR ¼ 26.6; 95%
CI ¼ 1.7-421.5).10
High Large
effect (1)
Risk of bias (1);
Imprecise (1);
Inconsistent (1)
 Transverse area of
the spinal cord;
Pavlov’s Index
Very Low  There is very low evidence (one prospective
observational study) that a larger transverse area of the
spinal cord (mean 76 mm2) (P < .05) and a higher Pavlov
Index (mean 0.9) (P < .05) are associated with improved
neurological status (JOA).9
High Risk of bias (1);
Imprecise (1);
Inconsistent (1)
 Other radiological
factors
Very Low  There is very low evidence (one prospective study using
multivariate analysis) that there is no significant
association between developmental or dynamic canal
factors, high T2WI signal intensity and neurological
deterioration (JOA).10
High Risk of bias (1);
Imprecise (1);
Inconsistent (1)
Clinical characteristics
 Initial level of
disability
Very Low  There is very low evidence (one prospective9 and one
retrospective17 observational study) that milder
disability before treatment is associated with greater
neurological improvement (JOA) (P < .05).
Low Imprecise (1)
 Duration of
disease
Very Low  There is very low evidence (2 retrospective
observational studies) that a shorter duration of
symptoms is associated with neurological improvement
(JOA) (P ¼ .001).13,17
Low Inconsistent (1)
 Range of motion Very Low  There is very low evidence (one retrospective study)
that greater neck range of motion (ROM) (P < .05),
greater head ROM (P < .01), and difference between
total head and neck ROM (P < .01) are associated with
progressively worse neurological condition (JOA).14
Low Inconsistent (1);
Imprecise (1)
Conversion to surgery
Demographic characteristics
 Age; sex Very Low  There is very low evidence (one retrospective study
using multivariate analysis) that there is no association
between age 60 years or sex and conversion to
surgery.19
Low Inconsistent (1);
Imprecise (1)
Radiographic characteristics
 Cervical range of
motion
 Segmental lordotic
angle
 Local slip
Very Low  There is very low evidence (one small retrospective
study, N ¼ 45 using multivariate analysis19) that there is
an association between increased risk of surgery and the
following factors:
 Total cervical range of motion (50) (adjusted
HR ¼ 3.3; 95% CI ¼ 1.03-10.25)
 Segmental lordotic angle (<0) (adjusted HR ¼ 4.5;
95% CI ¼ 1.59-12.8)
 Presence of a local slip (adjusted HR ¼ 4.7; 95%
CI ¼ 1.67-13.0)
Low Large
effect (1)
Imprecise (1);
Inconsistent (1)
(continued)
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secondary to OPLL (Table 3).6 This study had moderately high
risk of bias (Table 4).
Evidence Summary
The rate of hospitalization due to spinal cord injury was 4.8 per
1000 person-years in patients with DCM secondary to OPLL
and 13.9 per 1000 person-years in patients with CSM. The rate
of severe disability in DCM patients with OPLL was 3.4 per
1000 person-years. The strength of evidence for these estimates
was Low (Table 5).
Conclusions
The results of this update indicate that the presence of OPLL or
CSM may increase a patient’s risk of severe disability and hos-
pitalization for spinal cord injury. Although these findings are
unlikely to directly influence management strategies, patients
should be counseled of the possibility of spinal cord injury when
discussing the benefits and risks of various treatment options.
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